Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Oncotarget|December 2, 2017
Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinomaTakeharu Ono, Koichi Azuma, Akihiko Kawahara, et al.
Oncology Reports|June 6, 2007
Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patientsMasahiro Tanaka, Nobukazu Komatsu, Naoyoshi Terakawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patientsKoichi Azuma, Tetsuro Sasada, Hiroko Takedatsu, et al.
Cancer Cell International|December 10, 2022
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D culturesKazumasa Sekihara, Hidetomo Himuro, Nao Saito, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2021
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibodyYoshiro Nakahara, Takaji Matsutani, Yuka Igarashi, et al.
Immunopharmacology and Immunotoxicology|April 30, 2014
Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patientsKouichiro Kawano, Naotake Tsuda, Satoko Matsueda, et al.
Cancer Science|September 24, 2017
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinomaShigetaka Suekane, Kousuke Ueda, Kiyoaki Nishihara, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2008
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxelKoichi Azuma, Tetsuro Sasada, Akihiko Kawahara, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2010
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapyYohei Imamura, Koichi Azuma, Seiji Kurata, et al.
Oncology Reports|June 21, 2013
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patientsShigeru Yutani, Nobukazu Komatsu, Munehiro Yoshitomi, et al.
Pageof 14